Core Scientific Inc. (CORZ) sold off 7.37% after persistent downside pressure took hold, as the company announced its upcoming third-quarter 2026 earnings release and recent acquisition activity. The intensity of today's decline is supported by the stock's continued position below all its major moving averages, confirming dominant seller momentum.
Highlights
- Core Scientific completed its acquisition of Polaris DS and continues work to expand its Muskogee site to 1.5 GW of gross power.
- The company plans to release third-quarter 2026 financial results before market open on November 5, 2026, and supports data center infrastructure regulation in Texas.
- Shares of Core Scientific trade below key moving averages with firm downside momentum, projecting a high probability of further decline to $11.46 to $13.56 in the near term.
Expansion plans and Texas regulation fail to lift heavy seller flows
Core Scientific announced it will release its third-quarter 2026 financial results before market open on November 5, 2026, with a conference call and webcast the same day. The company completed its acquisition of Polaris DS, advancing an expansion project in Muskogee targeted at reaching 1.5 GW of gross power. Core Scientific also expressed public support for data center infrastructure regulation in Texas, though price action has remained under broader selling pressure.
Persistent downside momentum as key technicals stay firmly bearish
Core Scientific is trading below its short-, medium-, and long-term moving averages, with the current price at $12.51 compared to MA-20 at $16.58, MA-50 at $17.66, and MA-200 at $19.81. This indicates persistent seller pressure across all timeframes, with resistance at $13.44 and support at $11.46. The medium-term trend remains bearish, as confirmed by the MA-50 below the MA-200. Negative momentum dominates: MACD at -1.16, ADX at 26.84, and deep oversold conditions are shown by RSI at 29.29, Stochastic RSI at 0, and CCI at -172.65. Bearish intraday momentum is reinforced by a BBP of -0.66 and negative values in both AO and momentum indicators.
Earlier, analysts noted that Core Scientific was experiencing significant technical weakness and faced continued downside risks. The latest price action and indicator readings reinforce this bearish outlook, highlighting $11.46 as a critical support level to watch for any further breakdown.